SK
Subodh Kumar Sinha
About Subodh Kumar Sinha
Data last updated:
Subodh Kumar Sinha is a Director at Scafell Pharmaceuticals Private Limited (since 2022). The company operates in Healthcare. Scafell Pharmaceuticals Private Limited reported revenue of ₹55,745 (FY 2022).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 06 Apr 2022 | 2019 | ₹55,745 (FY 2022) | Active |
Board colleagues of Subodh Kumar Sinha
| Name | DIN | Company | Designation |
|---|---|---|---|
| Rajesh Kumar Singh | 08440237 | Scafell Pharmaceuticals Private Limited | Director |
| Ratnesh Kumar | 08440238 | Scafell Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Subodh Kumar Sinha
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Subodh Kumar Sinha
Subodh Kumar Sinha currently holds 1 directorship: Scafell Pharmaceuticals Private Limited (Director, since 06 Apr 2022, revenue ₹55,745 (FY 2022)).
Subodh Kumar Sinha was first appointed on 06 Apr 2022 as Director at Scafell Pharmaceuticals Private Limited.
The current boards of Subodh Kumar Sinha's companies include Rajesh Kumar Singh (Scafell Pharmaceuticals Private Limited), Ratnesh Kumar (Scafell Pharmaceuticals Private Limited).